Selective synthesis and retention of 66k protein in a human neuroblastoma cell line (NCG) treated with a cytotoxic dosage of δ12-prostaglandin J2

This publication has 20 references indexed in Scilit:

• Cycloheximide reduces PGD2 or Δ12-PGJ2 cytotoxicity on NCG cells
  Prostaglandins, 1986
• Cell kinetic studies of PGD2 cytotoxicity on the growth of human neuroblastoma
  Prostaglandins, Leukotrienes and Medicine, 1986
• Differential protection of normal and malignant human myeloid progenitors (CFU-GM) from Ara-C toxicity using cycloheximide
  Blood, 1985
• Δ12-prostaglandin J2, an ultimate metabolite of prostaglandin D2 exerting cell growth inhibition
  Biochemical and Biophysical Research Communications, 1985
• Prostaglandin D2 inhibits the proliferation of human malignant tumor cells
  Prostaglandins, 1984
• Prostaglandin D2 strongly inhibits growth of murine mastocytoma cells
  Prostaglandins, Leukotrienes and Medicine, 1983
• Cytotoxic action of prostaglandin D2 on mouse neuroblastoma cells
  International Journal of Cancer, 1983
• Inhibition of B-16 melanoma growth by prostaglandin D2
  Prostaglandins, 1983
• Prostaglandin D2, a potential antineoplastic agent
  Biochemical and Biophysical Research Communications, 1982
• Diminished toxicity of methotrexate in CD2F1 mice pretreated with cycloheximide
  Cancer Letters, 1982